SEC Filing Details

Document Details

Form
Filing Date
Sep 20, 2021
Document Date
Sep 10, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
PF EQUITY HOLDINGS 2 B.V.
Print Page
Email Alerts
RSS Feeds
Investor Contacts